Results 131 to 140 of about 12,382 (182)

Cross-Species Comparison between Mouse Kidney Multi-Omics and Human Genome-Wide Association Studies Highlights Molecular Features Associated with Oxalate Nephropathy. [PDF]

Kidney360
Chaya R, Taguchi K, Hashimoto Y, Shirai Y, Edahiro R, Sasa N, Yamamoto K, Tomofuji Y, Namba S, Sonehara K, Unno R, Hamamoto S, Okada A, Muroski J, Kato Y, Cristea IM, Okada Y, Yasui T.   +17 more
europepmc   +1 more source

Glucocorticoid-Induced Proteome and Phosphoproteome Changes in Breast Cancer Cell Lines. [PDF]

J Proteome Res
Cho H, Olsen JV.
europepmc   +1 more source

A comprehensive proteome and phosphoproteome atlas across nine organs of the Chinese hamster. [PDF]

Animal Model Exp Med
Zhang L, Ding T, Peng W, Kong J, Tang X, Xu J, Wang Q, Zhang Z, Shi C, Tian Y, Yang H, Yang Y, Wu Y, Liu X, Liu J, Yang J.   +15 more
europepmc   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model. [PDF]

Mol Oncol
Schwarzmüller L, Müller J, Vlachavas EI, Beumers L, Fleischhacker L, Burmester S, Wörner A, Karolus S, Helm D, Körner C, Wiemann S.   +10 more
europepmc   +1 more source

An Integrated Proteomics and Genomics Approach to Identify Essential Protein Kinases During Human Trophoblast Development. [PDF]

FASEB J
Kumar R, Dasgupta P, Ray S, Paul S.
europepmc   +1 more source

Reduced levels of ITGB1 cause activation of p38MAPK-ERK-LYN axis of BCR::ABL1 signaling despite inactivation of the oncoprotein by imatinib - novel resistance mechanism in blast crisis of chronic myeloid leukemia unraveled. [PDF]

Cell Commun Signal
Agrawal N, Narasimhan M, Mojidra R, Bagal B, Khattry N, Gokarn A, Punattar S, Govekar R.   +7 more
europepmc   +1 more source

Clinical Applications of Phosphoproteomics: Illuminating Cancer Signaling and Enabling Rational Therapeutic Strategies. [PDF]

Cancer Sci
Shoji H, Boku N, Adachi J.
europepmc   +1 more source

Meta-analysis of cellular phosphoproteome datasets exploring phospho-signaling associated with the RNA-binding protein RAVER1. [PDF]

Sci Rep
Sanjeev D, Mahin A, Prabhakar K, Subair S, Shivamurthy PB, Gopalakrishnan AP, Palollathil A, Raju R.   +7 more
europepmc   +1 more source

The phosphoproteome of ovarian carcinoma delineates signaling signatures and potentially druggable targets across histotype stages. [PDF]

NPJ Precis Oncol
Werner L, Esmaeili P, Ittner E, Swenson H, Kovács A, Mateoiu C, Dahm-Kähler P, Karlsson P, Parris T, Levander F, Helou K.   +10 more
europepmc   +1 more source